Joint treatments developer PainTEQ has secured a new US patent for its LinQ SI joint stabilisation system, designed to enhance precision and efficiency in sacroiliac (SI) joint fusion.
The patent expands PainTEQ’s single-use instrumentation portfolio and protects design features that improve procedural precision, efficiency, and patient safety. It introduces two key advancements in instrument alignment.
Claims 1-6 focus on using a joint locator with a keying protrusion for alignment with the cannula via a guidance slot. Claims 7-12 expand the design by reversing the roles, positioning the protrusion on the cannula and the joint locator with a channel to receive it.
The joint treatments developer said that these mechanisms offer a unique and effective approach to improve procedural accuracy and enhance patient outcomes.
PainTEQ marketing and research and development (R&D) director Jeremy Carr said: “PainTEQ’s mission is to transform SI joint dysfunction treatment, and this new patent underscores our commitment to delivering cutting-edge solutions that prioritise patient well-being.
“By continually innovating and expanding the capabilities of our LinQ System, we are setting new standards industrywide and improving quality of life for countless individuals who suffer from SI joint pain.”
This patent further strengthens PainTEQ’s intellectual property portfolio, which now features key advancements in alignment tools.
These patented technologies streamline surgical workflows, reduce outcome variability, and enhance safety with intuitive, single-use designs that boost efficiency in outpatient settings.
PainTEQ’s LinQ implant and single-use instruments deliver clinical benefits for individuals with debilitating lower back pain through a minimally invasive outpatient procedure.
The LinQ SI joint stabilisation system offers a minimally invasive solution for pain caused by sacroiliac disease.
After a thorough diagnosis, physicians can alleviate or even eliminate chronic pain by placing a single LinQ allograft into the SI joint.
Featuring a large graft window and patented instrumentation, the LinQ System creates an optimal environment for long-term fusion while ensuring procedural precision and efficiency.
In May, the Florida-based firm secured two new patents for its LinQ procedure.
The first patent covers the design of the LinQ allograft implant for the sacroiliac joint. The second patent pertains to the design of PainTEQ’s proprietary single-use joint decorticator tool, which prepares opposing bony surfaces for joint fusion.
